The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa-Reference-Cited by-同舟云学术

The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa

Published:2020-03-18 Issue:5 Volume:18 Page:475-483
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Mpobela Agnarson Abela¹,Williams Abeda²,Kambili Chrispin¹,Mattson Gunnar¹,Metz Laurent¹

Affiliation:

1. Johnson & Johnson Global Public Health, New Brunswick, NJ, USA

2. Janssen Pharmaceutical South Africa, Pharmaceutical Division of Johnson and Johnson, Johannesburg, South Africa

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2020.1742109

Reference50 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. World Health Organization. Global Tuberculosis Report 2017. WHO; 2018. [cited 2020 Feb 13]. Available from: https://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf

3. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling

4. World Health Organization. Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). WHO; 2018. [cited 2020 Dec 12]. Available from: https://www.who.int/tb/publications/2018/WHO_RapidCommunicationMDRTB.pdf

5. Bedaquiline: First FDA-approved tuberculosis drug in 40 years

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: Results from a mixed-method review of trends;PLOS ONE;2024-08-26

2. Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses;PharmacoEconomics;2024-08-07

3. A systematic review of economic evaluations of pharmacological treatments for active tuberculosis;Frontiers in Public Health;2024-04-16

4. A systematic review on cost-effectiveness of diagnostic methods and treatments for tuberculosis in India;Indian Journal of Tuberculosis;2024-04

5. Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens;Journal of Korean Medical Science;2023